Hims & Hers Health (HIMS) Common Equity (2019 - 2026)

Hims & Hers Health has disclosed Common Equity across 8 years of filings, most recently posting $446.2 million for Q1 2026.

• Common Equity for Q1 2026 came in at $446.2 million, down 18.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $446.2 million (down 18.77% YoY), and the FY2025 annual result was $540.9 million, up 13.47% from the prior year.
• Common Equity came in at $446.2 million for Q1 2026 at Hims & Hers Health, down from $540.9 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $581.0 million in Q3 2025 to a low of $310.9 million in Q3 2022.
• The 5-year median for Common Equity is $344.5 million (2024), against an average of $404.6 million.
• Across the five-year window, Common Equity jumped 59.45% in 2025 and retreated 18.77% in 2026, its largest moves.
• Hims & Hers Health's Common Equity stood at $311.7 million in 2022, then gained by 10.36% to $344.0 million in 2023, then surged by 38.57% to $476.7 million in 2024, then rose by 13.47% to $540.9 million in 2025, then retreated by 17.52% to $446.2 million in 2026.
• The last three Common Equity figures came in at $446.2 million (Q1 2026), $540.9 million (Q4 2025), and $581.0 million (Q3 2025), per Business Quant data.